Pilates exercise improves the clinical and immunological profiles of patients with human T-cell lymphotropic virus 1 associated myelopathy: A pilot study

J Bodyw Mov Ther. 2020 Jul;24(3):1-8. doi: 10.1016/j.jbmt.2020.02.012. Epub 2020 Feb 25.

Abstract

Background: HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an infectious chronic-inflammatory disease, which can lead to lower limb motions.

Methods: The study evaluated the effects of serial Pilates exercises on the clinical and immunological profiles of patients with HAM/TSP. Eight patients with ages ranging from 39 to 70 years old (2 males and 6 females), 2 wheelchair users and 6 with compromised gait, were evaluated. The patients were submitted to 20 Pilates sessions for 10 weeks. Data were collected at 3 time points (beginning of the study, after Pilates sessions and after 10 weeks without Pilates) and consisted of evaluations of the pain level, spasticity, motor strength, balance, mobility, functional capacity, quality of life and quantification of IFN-γ, IL-10 and IL-9 cytokines levels.

Results: After the Pilates sessions, significant improvements in pain level, static and dynamic balance, trunk control, mobility and quality of life were observed, with simultaneous and significant reductions in the serum levels of the cytokines IFN-γ and IL-10. However, after 10 weeks without Pilates, there were significant changes in terms of increasing pain and regression of mobility, with no changes in strength, spasticity, functional capacity in any of the periods of the study.

Conclusions: The results suggest that Pilates may be a promising auxiliary physical therapy for patients with HAM/TSP.

Keywords: Cytokines; HTLV-1; HTLV-1-Associated myelopathy; Pilates.

MeSH terms

  • Adult
  • Aged
  • Exercise Movement Techniques*
  • Exercise Therapy
  • Female
  • Human T-lymphotropic virus 1*
  • Humans
  • Interferon-gamma
  • Male
  • Middle Aged
  • Paraparesis, Tropical Spastic* / therapy
  • Pilot Projects
  • Quality of Life
  • T-Lymphocytes

Substances

  • Interferon-gamma